In Vivo Fitness Assessment of Drug Candidates
- Check with publisher
- Published date: November 28, 2019
-
- Shirley, New York, United States
Unspecific binding of drug candidates to other proteins is investigated in vitro using the protein microarray technique developed by our developability assessment groups. The objective of this assay is to provide a multitude of protein epitopes for the drug candidates and assess if the binding is restricted to the specifically designed target or not. In short, hundreds of different human proteins are respectively spotted on a nitrocellulose-coated surface, together with the binding target (antigen). In the best case, the tested candidate will only bind to its target. Problematic candidates may show binding affinities to both the target antigen and some of the other spotted proteins, an undesirable result that may influence the candidate ranking in the lead selection. https://www.creative-biolabs.com/drug-discovery/therapeutics/in-vivo-fitness-assessment-of-drug-candidates.htm





Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"
Related listings
-
15beta-PGF1α, Prostaglandins
Biological Sciences Shirley (New York) November 24, 2020 Check with publisherCD Bioparticles provides 15beta-PGF1α, Prostaglandins for drug delivery. C 67.38%; H 10.18%; O 22.44%. https://www.cd-bioparticles.net/p/7188/15beta-pgf1
-
PGF2β, Prostaglandins
Biological Sciences Shirley (New York) November 24, 2020 Check with publisherCD Bioparticles provides PGF2β, Prostaglandins for drug delivery. https://www.cd-bioparticles.net/p/7182/pgf2
-
11-beta PGF2α, Prostaglandins
Biological Sciences Shirley (New York) November 24, 2020 Check with publisherCD Bioparticles provides 11-beta PGF2α, Prostaglandins for drug delivery. C 67.77%; H 9.67%; O 22.57%. https://www.cd-bioparticles.net/p/7180/11-beta-pgf2